• 1
    Ries LAG, Eisner MP, Kosary CL, et al. SEER cancer statistics review, 1973-1999. Bethesda: National Cancer Institute. Available from URL: [Accessed 4 Dec 2002].
  • 2
    Gurney JG, Smith MA, Bunin GR. CNS and miscellaneous intracranial and intraspinal neoplasms. In: RiesLAG, SmithMA, GurneyJG, et al. Cancer incidence and survival among children and adolescents: United States SEER program 1975-1995 (NIH Publication No. 99-4649). Bethesda: National Cancer Institute, 1999: 5163.
  • 3
    Strother DR, Pollack IF, Fisher PG, et al. Tumors of the central nervous system. In: PizzoPA, PoplackDG. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams & Wilkins, 2002: 751824.
  • 4
    Anderson DM, Rennie KM, Ziegler RS, Neglia JP, Robison LR, Gurney JG. Medical and neurocognitive late effects among survivors of childhood central nervous system tumors. Cancer. 2001; 92: 27092719.
  • 5
    Mariotto A, Gigli A, Capocaccia R, et al. Complete and limited duration cancer prevalence estimates. In: RiesLAG, EisnerMP, KosaryCL, et al. SEER cancer statistics review, 1973-1999. Bethesda: National Cancer Institute, 2002. Available from URL: [Accessed 4 Dec 2002].
  • 6
    Davis FG, Kupelian V, Freels S, McCarthy B, Surawicz T. Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neurooncology. 2001; 3: 152158.
  • 7
    Packer RJ, Meadows AT, Rorke LB, Goldwein JL, D'Angio G. Long-term sequelae of cancer treatment on the central nervous system in childhood. Med Pediatr Oncol. 1987; 15: 241253.
  • 8
    Robison LL, Mertens AC, Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002; 38: 229239.
  • 9
    Rubin DB. Multiple imputation for nonresponse in surveys. New York: John Wiley & Sons, 1987.
  • 10
    Taylor JM, Munoz A, Bass SM, Saah AJ, Chmiel JS, Kingsley LA. Estimating the distribution of times from HIV seroconversion to AIDS using multiple imputation: multicentre AIDS cohort study. Stat Med. 1990; 9: 505514.
  • 11
    Therneau MT, Grambsch PM. Modeling survival data extending the Cox model. New York: Springer, 2000.
  • 12
    Livesey EA, Hindmarsh PC, Brook CG, et al. Endocrine disorders following treatment of childhood brain tumours. Br J Cancer. 1990; 61: 622625.
  • 13
    Oberfield SE, Allen JC, Pollack J, New MI, Levine LS. Long-term endocrine sequelae after treatment of medulloblastoma: prospective study of growth and thyroid function. J Pediatr. 1986; 108: 219223.
  • 14
    Tomita T. Long-term effects of treatment for childhood brain tumors. Neurosurg Clin North Am. 1992; 3: 959971.
  • 15
    Sklar CA, Constine LS. Chronic neuroendocrinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys. 1995; 31: 11131121.
  • 16
    Stewart JR, Fajardo LF, Gillette SM, Constine LS. Radiation injury to the heart. Int J Radiat Oncol Biol Phys. 1995; 31: 12051211.
  • 17
    Heikens J, Ubbink MC, van der Pal HP,et al. Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease. Cancer. 2000; 88: 21162121.
  • 18
    O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999; 340: 1422.
  • 19
    Jakacki RI, Goldwein JW, Larsen RL, Barber G, Silber JH. Cardiac dysfunction following spinal irradiation during childhood. J Clin Oncol. 1993; 11: 10331038.
  • 20
    Ogilvy-Stuart AL, Shalet SM, Gattamaneni HR. Thyroid function after treatment of brain tumors in children. J Pediatr. 1991; 119: 733737.
  • 21
    Livesey EA, Brook CG. Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours. Arch Dis Child. 1989; 64: 593595.
  • 22
    Chin D, Sklar C, Donahue B, et al. Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/primitive neuroectodermal tumors: a comparison of hyperfractionated versus conventional radiotherapy. Cancer. 1997; 80: 798804.
  • 23
    Sklar C, Whitton J, Mertens A, et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab. 2000; 85: 32273232.